Anew artificial intelligence (AI) platform is poised to radically change the way the pharmaceutical industry develops new drugs while dramatically cutting the cost of medical trials.
The technology, developed by GATC Health, can predict with 87 percent accuracy whether a new medication will be safe and effective in a clinical trial. The AI platform is so accurate that Medical and Commercial International Limited (MCI), a syndicate of the Lloyd's of London insurance marketplace, is partnering...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek